- Report
- April 2025
- 375 Pages
Global
From €5324EUR$5,850USD£4,564GBP
- Report
- August 2024
- 142 Pages
Global
From €2729EUR$2,999USD£2,340GBP
- Report
- April 2023
- 103 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Report
- August 2024
- 84 Pages
Global
From €3500EUR$4,120USD£3,106GBP
The Hirsutism Drug market is a subset of the Endocrine and Metabolic Disorders Drugs market. Hirsutism is a condition characterized by excessive hair growth in women, usually in areas where men typically have hair. Common treatments for hirsutism include oral contraceptives, anti-androgens, and laser hair removal. Oral contraceptives are used to reduce the production of androgens, while anti-androgens are used to block the action of androgens. Laser hair removal is used to reduce the amount of hair in the affected areas.
The Hirsutism Drug market is highly competitive, with a number of companies offering products to treat the condition. Some of the major players in the market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Other companies in the market include Allergan, Mylan, and Teva Pharmaceuticals. Show Less Read more